Novartis plant saved for another year as closure delayed

Thursday, 21 May 2020, 16:55:48
Pharmaceutical giant confirms it is keeping large parts of plant open and retaining staff
— Grimsby Live

Stay of execution for huge Novartis pharmaceutical plant

Thursday, 21 May 2020, 16:26:06
Grimsby site to be retained for a further year after initial 2020 closure pushed back
— Business Live

Novartis Gets EC Approval for Gene Therapy Zolgensma in SMA

Tuesday, 19 May 2020, 14:52:00
Novartis’ (NVS) gene therapy, Zolgensma, obtains EC approval for spinal muscular atrophy.
— Zacks Investment Research

Novartis : Zolgensma Gets Conditional EU Approval | MarketScreener

Tuesday, 19 May 2020, 06:05:03
By Olivia Bugault Novartis AG said Tuesday that its Zolgensma gene therapy for patients with spinal muscular atrophy has been conditionally approved in Europe. The European Commission… | May 19, 2020
— MarketScreener

Regenerative Medicine Industry Outlook to 2025 Featuring Novartis, Vericel, Integra Lifesciences, Mimedx Group, Stryker, Wright Medical, Roche and More

Thursday, 14 May 2020, 13:00:00
DUBLIN, May 14, 2020 /PRNewswire/ — The “Global Regenerative Medicine Market By Therapy (Cell-Based Immunotherapy & Cell Therapy, Gene Therapy, Others), By Application, By Material, By Cell, By Product, By Technique, By Distribution Channel, By Region, Forecast & Opportunities, 2025″…
— PR Newswire